BIOMAT Database Logo BIOMAT Database Logo

Antivertigo agents. III. Synthesis of 5,6,7,8-tetrahydro-1,6-naphthyridine methyl homologs. 1984

A Shiozawa, and Y Ichikawa, and C Komuro, and S Kurashige, and H Miyazaki, and H Yamanaka, and T Sakamoto

UI MeSH Term Description Entries
D009287 Naphthyridines A group of two-ring heterocyclic compounds consisting of a NAPHTHALENES double ring in which two carbon atoms, one per each ring, are replaced with nitrogens.
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014717 Vertigo An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1) CNS Origin Vertigo,Central Nervous System Origin Vertigo,Positional Vertigo,Spinning Sensation,Vertigo, Brain Stem,Vertigo, Brainstem,Vertigo, Central Nervous System Origin,Vertigo, Central Origin,Vertigo, Constant,Vertigo, Essential,Vertigo, Intermittant,Vertigo, Paroxysmal,Vertigo, Peripheral,Vertigo, Subjective,Brain Stem Vertigo,Brain Stem Vertigos,Brainstem Vertigo,Brainstem Vertigos,CNS Origin Vertigos,Central Origin Vertigo,Central Origin Vertigos,Constant Vertigo,Constant Vertigos,Essential Vertigo,Essential Vertigos,Intermittant Vertigo,Intermittant Vertigos,Origin Vertigo, CNS,Origin Vertigo, Central,Origin Vertigos, CNS,Origin Vertigos, Central,Paroxysmal Vertigo,Paroxysmal Vertigos,Peripheral Vertigo,Peripheral Vertigos,Sensation, Spinning,Sensations, Spinning,Spinning Sensations,Subjective Vertigo,Subjective Vertigos,Vertigo, CNS Origin,Vertigo, Positional,Vertigos,Vertigos, Brain Stem,Vertigos, Brainstem,Vertigos, CNS Origin,Vertigos, Central Origin,Vertigos, Constant,Vertigos, Essential,Vertigos, Intermittant,Vertigos, Paroxysmal,Vertigos, Peripheral,Vertigos, Subjective
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

A Shiozawa, and Y Ichikawa, and C Komuro, and S Kurashige, and H Miyazaki, and H Yamanaka, and T Sakamoto
5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors.
February 2019, Journal of medicinal chemistry,
A Shiozawa, and Y Ichikawa, and C Komuro, and S Kurashige, and H Miyazaki, and H Yamanaka, and T Sakamoto
Library synthesis using 5,6,7,8-tetrahydro-1,6-naphthyridines as scaffolds.
January 2008, Journal of combinatorial chemistry,
A Shiozawa, and Y Ichikawa, and C Komuro, and S Kurashige, and H Miyazaki, and H Yamanaka, and T Sakamoto
Asymmetric Synthesis of a 5,6,7,8-Tetrahydro-1,6-naphthyridine Scaffold Leading to Potent Retinoid-Related Orphan Receptor γt Inverse Agonist TAK-828F.
August 2020, The Journal of organic chemistry,
A Shiozawa, and Y Ichikawa, and C Komuro, and S Kurashige, and H Miyazaki, and H Yamanaka, and T Sakamoto
Methods for the synthesis of 5,6,7,8-tetrahydro-1,8-naphthyridine fragments for alphaVbeta3 integrin antagonists.
December 2004, The Journal of organic chemistry,
A Shiozawa, and Y Ichikawa, and C Komuro, and S Kurashige, and H Miyazaki, and H Yamanaka, and T Sakamoto
Cardiotonic agents. 1-Methyl-7-(4-pyridyl)-5,6,7,8-tetrahydro-3 (2H)-isoquinolinones and related compounds. Synthesis and activity.
February 1989, Journal of medicinal chemistry,
A Shiozawa, and Y Ichikawa, and C Komuro, and S Kurashige, and H Miyazaki, and H Yamanaka, and T Sakamoto
Synthesis of 5,6,7,8-tetrahydro-1,6-naphthyridines and related heterocycles by cobalt-catalyzed [2 + 2 + 2] cyclizations.
February 2007, Organic letters,
A Shiozawa, and Y Ichikawa, and C Komuro, and S Kurashige, and H Miyazaki, and H Yamanaka, and T Sakamoto
Synthesis of 1,2,3,4-tetrahydro-beta-carboline derivatives as hepatoprotective agents. III. Introduction of substituents onto methyl 1,2,3,4-tetrahydro-beta-carboline-2-carbodithioate.
August 1987, Chemical & pharmaceutical bulletin,
A Shiozawa, and Y Ichikawa, and C Komuro, and S Kurashige, and H Miyazaki, and H Yamanaka, and T Sakamoto
5,6,7,8-Tetrahydro-iso-chinolin (Bz-Tetrahydro-iso-chinolin).
January 1947, Helvetica chimica acta,
A Shiozawa, and Y Ichikawa, and C Komuro, and S Kurashige, and H Miyazaki, and H Yamanaka, and T Sakamoto
Synthesis of antimicrobial agents. III. Synthesis and antimicrobial activities of thiazolo[5,4-b]naphthyridine derivatives.
February 1979, Chemical & pharmaceutical bulletin,
A Shiozawa, and Y Ichikawa, and C Komuro, and S Kurashige, and H Miyazaki, and H Yamanaka, and T Sakamoto
Synthesis of cis- and trans-5,8-dihydroxy-5,6,7,8-tetrahydro-1,4-naphthoquinone.
October 2001, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!